Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Identification of novel candidate plasma metabolite biomarkers for distinguishing serous ovarian carcinoma and benign serous ovarian tumors

Published:2016-01 Issue:1 Volume:140 Page:138-144
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Buas Matthew F.,Gu Haiwei,Djukovic Danijel,Zhu Jiangjiang,Drescher Charles W.,Urban Nicole,Raftery Daniel,Li Christopher I.

Funder

NIH Metabolomics Common Fund

NIH

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference40 articles.

1. Cancer statistics, 2015;Siegel;CA Cancer J. Clin.,2015

2. Engelen MJ A, Kos HE, Willemse PHB, et al. (2006) Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma. Cancer 106: 589–98. http://dx.doi.org/10.1002/cncr.21616

3. A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass;Moore;Gynecol. Oncol.,2009

4. Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors;Ueland;Obstet. Gynecol.,2011

5. Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: potential use in diagnosis and prognosis;Kozak;Proc. Natl. Acad. Sci. U. S. A.,2003

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Contribution of Lipidomics in Ovarian Cancer Management: A Systematic Review;International Journal of Molecular Sciences;2023-09-11

2. Multi-omic assessment shows dysregulation of pulmonary and systemic immunity to e-cigarette exposure;Respiratory Research;2023-05-25

3. Complex metabolic interactions between ovary, plasma, urine, and hair in ovarian cancer;Frontiers in Oncology;2022-08-02

4. Current and Emerging Methods for Ovarian Cancer Screening and Diagnostics: A Comprehensive Review;Cancers;2022-06-11

5. Recent advances in LC‐MS‐based metabolomics for clinical biomarker discovery;Mass Spectrometry Reviews;2022-05-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3